Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0029713 (
immaturity
)
4,335
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Consistent with previous findings, six women with primary
anorexia nervosa
who underwent 24-hour endocrine studies were all observed to have immature (prepubertal or pubertal) patterns of circadian luteinizing hormone (LH) secretion. This abnormality was present despite negligible weight deficit (but active symptomatology) in three of the women. Regardless of the extent of
immaturity
of circadian pattern, each woman showed a completely normal release of LH in response to the single intravenous administration of luteinizing hormone releasing hormone (LHRH). These findings provide further evidence for the intactness of pituitary function and for the possibility of a functional hypothalamic disturbance in
anorexia nervosa
. The discrepant finding in certain other studies of inadequate LH response to LHRH in women with
anorexia nervosa
is reviewed, and the potential influences of differing variables in these studies and the possibility of a heterogeneous illness are emphasized.
...
PMID:LHRH responsiveness in anorexia nervosa: intactness despite prepubertal circadian LH pattern. 33 84
In previous studies we had established that emaciated women with active primary
anorexia nervosa
(AN) had immature 24-hr luteinizing hormone (LH) secretory patterns. In this study, we have examined the circadian LH patterns of eight women with AN who had partially or fully recovered their ideal weights. Three of the women were studied before and after weight gain and five women were studied only after the appearance of binge-eating and consequent weight gain (by history). Our findings are: (1) The adult (mature) circadian LH secretory pattern was not present in women who had partially or totally achieved ideal weight but who otherwise remained symptomatic; (2) those women who showed both weight gain and normalization of LH pattern were also symptomatically improved in other respects; (3) the degree of
immaturity
of pattern did not correlate reliably with the duration of illness, the degree of fatness, or the extent of deficit from ideal weight; (4) the mode of illness onset and the type of secretory pattern were not related; and (5) the return of menses did not show a simple relationship to weight, fatness, or maturity of LH pattern.
...
PMID:Weight and circadian luteinizing hormone secretory pattern in anorexia nervosa. 74 Aug 42
The relationship of selected pretreatment characteristics to weight gain during treatment was examined in 81
anorexia nervosa
patients. Good prognostic indicators correlating positively with weight gain were: no previous hospitalizations for
anorexia nervosa
, a great amount of overactivity before treatment, less denial of illness, less psychosexual
immaturity
and the admission to feeling hunger. A perinatal history of delivery complications was associated with the poor outcome predictor of prior hospitalizations.
...
PMID:Pretreatment predictors of outcome in anorexia nervosa. 76 Sep 25
It appears certain that the causes of self-destructive dermatoses are many and complex. The disorder spans diagnostic categories and varies from unconscious picking at the skin to severe self-destructive actions. Although not limited to any one diagnosis, skin disorders appear to be more prevalent in depression. This association may involve activation of the hypothalamic-pituitary-adrenal axis commonly found in depression. Two specific types of commonly occurring dermatoses-neurotic excoriations and dermatitis artefacta-are reviewed in this article. The major distinction of these disorders centers on whether the patient can admit to self-mutilation. Because of the difficulties in dermatitis artefacta with insight and body-image, it has been compared with
anorexia nervosa
. Often, dermatitis artefacta coexists with
anorexia nervosa
. In both disorders, neurotic excoriations and dermatitis artefacta, the personality style tends to be introverted with emotional
immaturity
. These patients have difficulty when they are under stress; the problem is compounded because of poor communication skills. Pharmacotherapy is of limited usefulness, and psychotherapy is often times hindered by strong resistance to exploring long-standing emotional issues. Once an alliance is established with the therapist, however, these issues may be examined. Prognosis is variable but does seem to directly correlate with the duration of the illness. Young individuals may experience alleviation of symptoms after one session of psychotherapy, whereas older patients may never have resolution. Dermatologic abuse involving psychosis has many presentations; one of the most common involves infestation. Organic causes must always be excluded as part of the differential diagnosis. In schizophrenia, this presentation has one of the highest incidences of suicide.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Self-destructive dermatoses. 389 93
Fifty-one cases of
anorexia nervosa
(AN) and 51 age-, sex- and school-matched controls, all drawn from a community sample of 15- to 16-year-olds, were compared at 16 and 21 years with regard to physical health and neurodevelopment. The AN group had significantly lower mean height than the comparison group at age 21 years. There were significantly more individuals that were overweight and underweight in the AN group at age 21 years. Fractures were slightly, but significantly, more common. Dysdiadochokinesis was very much more common in the AN group at both ages, and its occurrence was not correlated with low weight. It is suggested that diadochokinesis in AN might mirror some inherent underlying
immaturity
or other abnormality of the central nervous system in a subgroup of cases. The presence of dysdiadochokinesis was associated with a tendency towards poorer psychosocial outcome, even in cases that were no longer underweight.
...
PMID:Anorexia nervosa: physical health and neurodevelopment at 16 and 21 years. 803 18